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Purpose: To compare the incidence and clinical characteristics of retinal detachments (RDs) 
diagnosed in a tertiary eye emergency department (EED) during the COVID-19 pandemic 
and in the corresponding period of the previous 4 years.
Methods: EED consultations performed from February 21, 2020 (first national case of 
COVID-19 infection) to May 3, 2020 (end of lockdown imposed by national Government) 
and for the same date range of 2016–2019 (pre-COVID-19 period), and with a confirmed 
diagnosis of RD were collected and reviewed. The following demographical and clinical 
features have been analyzed: age, gender, etiology of RD, macular involvement, best 
corrected visual acuity (BCVA), and duration of experienced symptoms.
Results: Eighty-two subjects (20.5±1.0 eyes/year) were diagnosed with RD in the pre- 
COVID-19 period, compared to 12 patients in the COVID-19 period (−41.5%). During the 
pandemic, patients complained symptoms for a median of 8.5 days (IQR, 1.7–15 days) 
before the EED consultation, while in the pre-COVID-19 period, they declared they had been 
symptomatic for 2 days (IQR, 1–4 days) (p=0.037); macula-off RD raised from 56% to 75% 
and no one reported trauma as a triggering event.
Conclusion: During the COVID-19 pandemic, the rate of RD diagnosed in our EED 
decreased significantly and patients waited longer before asking for an ophthalmologic 
examination. These findings are probably due to the fear of contracting the COVID-19 
infection attending hospital environments. Even if emergency departments are often misused 
by people suffering non-urgent conditions, patients complaining of sudden visual loss, visual 
field defects, or phosphenes should always and promptly attend an EED visit to prevent 
a worse prognosis.
Keywords: COVID-19 pandemic, eye emergency department, EED, eye, lockdown, retinal 
detachment, RD
Introduction
The first diagnosed case of COVID-19 in Italy dates back to February 21, 2020, and 
the Italian government imposed a national lockdown from March 9, 2020 to May 3, 
2020. The pandemic led to a significant reduction of daily clinical and surgical 
activities and a rescheduling of the visits for chronic conditions, as reported by 
colleagues from different countries.1–4 These changes were partially due to the 
National Health System directives and to the strict restrictions imposed on people’s 
habits and mobility, but also to the patient’s fear of getting the infection attending 
the hospital environment. Thus, a delay in the management of chronic and acute 
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diseases occurred, with negative effects for patients’ visual 
outcomes.1 Despite our eye emergency department (EED) 
stayed open during the lockdown, overall we observed 
a drop of 62% in eye emergency consultations when 
compared to the same period of 2019. Even if most of 
the patients that preferred not to attend the EED were 
those that complained milder conditions, we also noted 
a reduction of urgent pathologies, and especially of retinal 
detachments (RDs). RD is an eye emergency that can lead 
to a rapid vision loss.5 In Europe, it has an incidence of 1/ 
10,000 people per year.6 Rhegmatogenous retinal detach-
ment is the most common type. The associated risk factors 
are peripheral rhegmatogenous retinal degenerations, 
pathological myopia, previous intraocular surgery, history 
of RD in the fellow eye, trauma and positive family 
history.7 At presentation, the major risk factors associated 
with poor post-surgical visual outcomes are a latency of 
more than 6 days from the onset of symptoms and macular 
involvement.8–11 If left untreated, retinal detachment can 
progress to complete detachment, resulting in loss of 
visual function.12,13 This study aims to evaluate the inci-
dence and clinical characteristics of RDs diagnosed in an 
Italian tertiary eye center during the first wave of pan-
demic and to compare them with those of the same period 
of the previous 4 years.
Materials and Methods
EED consultations performed from February 21, 2020 to 
May 3 2020 and in the same date range of 2016–2017– 
2018–2019 (pre-COVID-19 period), and with a confirmed 
diagnosis of RD were retrieved and reviewed. The study 
protocol was previously approved by the Ethics 
Committee of our Institution. All data were collected 
anonymously and following the ethical standards of the 
Declaration of Helsinki. All patients admitted at the EED 
gave consent to the processing of personal data. The 
following demographic and clinical features at presenta-
tion have been analyzed: age, gender, etiology of RD 
(idiopathic, traumatic or post-surgical), macular involve-
ment (macula-on or macula-off), best corrected visual 
acuity (BCVA) in LogMAR and duration of experienced 
symptoms. To express in LogMAR the visual acuity of 
“counting fingers”, “hand motion”, and “light perception” 
we followed the conversion table published by Schulze- 
Bonsel et al.14 Macular involvement was evaluated with 
fundoscopy and OCT when possible, or B-scan ultrasono-
graphy for cases presenting with vitreous hemorrhage. 
Since the demographic and clinical characteristics of 
patients admitted from 2016 to 2019 (pre-COVID-19 per-
iod) did not statistically differ for all the analyzed features, 
they were considered as a single group and compared to 
2020 (COVID-19 period) ones (Supplementary Table 1).
Statistical Analysis
Descriptive statistics were reported using percentage for 
categorical variables, mean ± Standard Deviation (SD) for 
age, and median with interquartile range (IQR) for BCVA. 
The normality of quantitative variables (age and BCVA) 
was assessed with Shapiro–Wilk test. Differences in cate-
gorical variables, age, and BCVA between the two groups 
(COVID-period vs pre-COVID period) were tested using 
respectively Fisher’s exact test, t-test for independent 
means and Mann–Whitney U-test. The analysis was done 
using STATA 16.0 (StataCorp, Texas, USA) and statistical 
significance was set at a p-value <0.05.
Results
Eighty-two subjects (20.5±1.0 eyes/year) were diagnosed 
with RD in the pre-COVID-19 period, compared to 12 
patients in the COVID-19 period (−41.5%). During the 
pandemic, patients complained symptoms for a median 
of 8.5 days (IQR, 1.7–15 days) before the EED consulta-
tion, while in the pre-COVID-19 period, they declared that 
have been symptomatic for a median of 2 days (IQR, 1–4 
days) (p=0.037), Figure 1. In 2020, the macula-off RDs 
raised from 56% to 75% (p=0.347) and no patient reported 
trauma as triggering event. No significant differences were 
found in presenting age, gender, etiology of RD, macular 
involvement, BCVA and complained symptoms between 
the pre-COVID-19 and COVID-19 period (Table 1).
Discussion
In this study, we have evaluated the demographic and ophthal-
mological characteristics of patients diagnosed with RD in 
a tertiary EED center during the first wave of COVID-19 
pandemic. A significant reduction in the incidence of RD 
occurred in comparison to the same period of the previous 
four years (Table 1). To reduce the impact of known season-
ality in RDs,15,16 the study period was compared with the 
same day interval of the previous years. The 2020 cohort 
included fewer patients than in the pre-COVID-19 period. 
We decided not to investigate the long-term post-surgical 
visual outcomes of RDs, because that was not the aim of this 
study. In 2020, none of the enrolled patients, once swab tested, 
resulted positive to COVID-19. This factor might have resulted 
in a delay of presentation at the EED. The reduction in the 
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number of RDs in our study (−41.5%) is lower than that 
reported by Poyser et al (−65.7%).2 Even in our sample, we 
have experienced an increase of the macula-off RDs (from 
56% to 75%), nevertheless, we cannot confirm the findings of 
Patel et al because we did not reach the statistical significance 
(p=0.347), purportedly due to the small sample size.3 In the 
same period, we have also observed a 50.9% (pCG: 57 subjects 
vs CG: 7 subjects) and a 39.5% (pCG: 271 subjects vs CG: 41 
subjects) reduction in the occurrence of retinal tears and poster-
ior vitreous detachments respectively. A limitation of the pre-
sent research is that only the patients who came to our EED 
during the study period have been included for statistical 
analysis, probably excluding those who presented with 
a longer delay. However, a further check on the consultancies 
Table 1 Comparison of Demographical and Clinical Characteristics of Enrolled Patients Between the Two Periods
Pre-COVID-19 Period (n=82) COVID-19 Period (n=12) p-value
Age, years 59.8 ± 13.1 54.3 ± 13.6 0.088
Gender, males (%) 67 58 0.550





BCVA, LogMAR 1.0 (2.3–0.2) 0.7 (1.6–0.4) 0.834
RD type (%) 0.347
M-On 44 25
M-Off 56 75
Experienced symptoms (%) 0.579
Visual loss 67 58
VF defects 34 17
Phosphenes 27 33
Abbreviations: BCVA, best corrected visual acuity; M-On, macula-on; M-Off, macula-off; RD, retinal detachment; VF, visual field.
Figure 1 Duration of complained symptoms reported by patients at presentation.
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over the following two months and after the end of the lock-
down, revealed that 5 out of 9 patients diagnosed with RD have 
been complaining for ocular symptoms during the quarantine. 
Our study shows some negative effects of the COVID-19 
pandemic on ophthalmological emergencies.4 Similar to 
other groups, we hypothesized that patients preferred to post-
pone the access to EED and endure their visual symptoms 
rather than going to the hospital and risking to contract the 
COVID-19 infection.17,18 A further contribution to the reduc-
tion of the incidence of RDs can be explained with the absence 
of those of secondary etiology: the post-surgical RDs, due to 
the suspension of the scheduled surgical activity, and the post- 
traumatic ones due to the limitations imposed on the work and 
sportive activity. Eventually, to avoid the hospital environment, 
some patients might have preferred to attend private eye clinics 
for the treatment of their eye condition. If not restricted, even 
opticians could see patients and recommend an urgent exam-
ination to those who complained of symptoms suspicious for 
RD. Since the timing in RD treatment is crucial for the prog-
nosis, an immediate consultation with an ophthalmologist is 
fundamental should specific visual symptoms occur.19,20 Acute 
pathologies with complications also have a considerable social 
cost, so it is appropriate to emphasize the importance of not to 
underestimate such symptoms as a sudden loss or vision 
decline, visual field defects and phosphenes. Although the 
increase in number of macula-off RDs, the median BCVA of 
patients visited during the lockdown was slightly higher than in 
the pre-COVID-19 period. This controversial result can be 
attributed to the lower number of contextual vitreous hemor-
rhage (3.5 vs 1.0 vitreous hemorrhage per-year in pre-COVID 
-19 and COVID-19 period, respectively). Given the study 
design and how it has been carried out, it is not possible to 
apply the data to the population level. Considering the persis-
tence of COVID-19 across the world and potential recurrent 
waves of the pandemic, we underline the need for lifelong 
public education concerning visual symptoms and the impor-
tance of a constant ophthalmological care. Probably, if 
a telemedicine system had been activated when the COVID- 
19 pandemic started, patients with suspected RD would have 
been invited to go immediately to the EED. Conversely, those 
who complained milder symptoms, predominantly related to 
the ocular surface diseases, would have been handled and 
treated at home. Had this procedure been followed, situations 
like overcrowded EDs subjected to a stressful work schedule 
due to the management of COVID-19 patients could have been 
avoided, the spread of infection could have been limited and 
more time and resources could have been devoted to cases that 
required a prompt assistance, and even surgery, such as RDs.
Conclusion
The rate of RD diagnosed in our EED decreased signifi-
cantly during the COVID-19 pandemic (−41.5%) and 
patients waited longer before asking for an ophthalmologic 
examination. These findings are probably due to the fear of 
contracting the COVID-19 infection attending hospital 
environments. Since we will have to live with the 
COVID-19 infection for some time, it is fundamental 
that patients consider hospitals as safe places, where they 
can be cared for and treated as in the period before the 
outbreak. Even if Emergency Departments are often mis-
used by people suffering non-urgent conditions, patients 
complaining of sudden visual loss, visual field defects, or 
phosphenes should always and promptly attend an EED 
visit to prevent a worse prognosis.
Abbreviations
BCVA, best corrected visual acuity; EED, eye emergency 
department; RD, retinal detachment.
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